← Leaderboards
Raymond J Monnat
University Of Washington
$11,516,060
Attributed
$13,290,264
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$39,286,961 · 15
By mechanism
P01$31,855,986 · 9
R01$5,494,761 · 3
RL1$1,918,214 · 1
R13$18,000 · 2
Top collaborators
- Albert Folch5 shared
- Robert C Rostomily5 shared
- Laura E Hays1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Lawrence A Loeb$30,079,700
- Richard Goff James$5,481,094
- Junko Oshima$3,761,782
- Peter S Rabinovitch$49,936,459
- George M. Martin$5,470,369
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResponseProgramsHelicaseResearch PersonnelTumorProteinsGene MutationMolecularBaseCellsDecision MakingLinkInnovationMutantGeneticGenomicsClinically RelevantSiteTreatment ResponseVariantCancer TherapyBiologyHeterogeneity
Grant awards (73)
Molecular Determinants of Cancer Therapeutic Response$1,414,467
P01 · FY2019 · CA · contact PI
Replication Stress Signatures$290,658
P01 · FY2019 · CA · contact PI
Program Administration$181,492
P01 · FY2019 · CA · contact PI
Molecular Determinants of Cancer Therapeutic Response$1,458,213
P01 · FY2018 · CA · contact PI
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures$532,112
R01 · FY2018 · CA
Replication Stress Signatures$361,839
P01 · FY2018 · CA · contact PI
Program Administration$79,291
P01 · FY2018 · CA · contact PI
Molecular Determinants of Cancer Therapeutic Response$1,458,213
P01 · FY2017 · CA · contact PI
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures$532,112
R01 · FY2017 · CA
Functional phenotyping of human genetic variation$386,250
R01 · FY2017 · HL · contact PI
Replication Stress Signatures$361,839
P01 · FY2017 · CA · contact PI
Program Administration$79,291
P01 · FY2017 · CA · contact PI
Molecular Determinants of Cancer Therapeutic Response$1,458,213
P01 · FY2016 · CA · contact PI
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures$532,112
R01 · FY2016 · CA
Functional phenotyping of human genetic variation$386,250
R01 · FY2016 · HL · contact PI
Replication Stress Signatures$361,839
P01 · FY2016 · CA · contact PI
Program Administration$79,291
P01 · FY2016 · CA · contact PI
RECQ2016 - Partnering for Progress$8,000
R13 · FY2016 · CA · contact PI
Molecular Determinants of Cancer Therapeutic Response$1,471,838
P01 · FY2015 · CA · contact PI
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures$532,112
R01 · FY2015 · CA
Functional phenotyping of human genetic variation$380,456
R01 · FY2015 · HL · contact PI
Replication Stress Signatures$361,839
P01 · FY2015 · CA · contact PI
Program Administration$79,291
P01 · FY2015 · CA · contact PI
27th Annual Fanconi Anemia Research Fund Scientific Symposium$10,000
R13 · FY2015 · HL · contact PI
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures$525,358
R01 · FY2014 · CA
Functional phenotyping of human genetic variation$386,250
R01 · FY2014 · HL · contact PI
Human RecQ helicases in biology and oncology$1,343,711
P01 · FY2013 · CA · contact PI
Functional Genomics$253,892
P01 · FY2013 · CA · contact PI
Administrative and Statistical Core$77,667
P01 · FY2013 · CA · contact PI
Human RecQ helicases in biology and oncology$1,436,456
P01 · FY2012 · CA · contact PI
Functional Genomics$270,981
P01 · FY2012 · CA · contact PI
Administrative and Statistical Core$86,032
P01 · FY2012 · CA · contact PI
Human RecQ helicases in biology and oncology$1,442,050
P01 · FY2011 · CA · contact PI
NEW LAGLIDADG HOMING ENDONUCLEASES FOR GENOME ENGINEERING (Component 2 of 11)$374,818
RL1 · FY2011 · CA · contact PI
Functional Genomics$271,886
P01 · FY2011 · CA · contact PI
Administrative and Statistical Core$89,432
P01 · FY2011 · CA · contact PI
Human RecQ helicases in biology and oncology$1,501,977
P01 · FY2010 · CA · contact PI
NEW LAGLIDADG HOMING ENDONUCLEASES FOR GENOME ENGINEERING (Component 2 of 11)$323,062
RL1 · FY2010 · CA · contact PI
Functional Genomics$281,489
P01 · FY2010 · CA · contact PI
Administrative and Statistical Core$92,498
P01 · FY2010 · CA · contact PI
Human RecQ helicases in biology and oncology$1,476,952
P01 · FY2009 · CA · contact PI
NEW LAGLIDADG HOMING ENDONUCLEASES FOR GENOME ENGINEERING (Component 2 of 11)$450,706
RL1 · FY2009 · CA · contact PI
Functional Genomics$275,695
P01 · FY2009 · CA · contact PI
Administrative and Statistical Core$67,968
P01 · FY2009 · CA · contact PI
Genetic Instability in Werner Syndrome$1,367,754
P01 · FY2008 · CA · contact PI
NEW LAGLIDADG HOMING ENDONUCLEASES FOR GENOME ENGINEERING (Component 2 of 11)$382,428
RL1 · FY2008 · CA · contact PI
Cell Function$262,585
P01 · FY2008 · CA · contact PI
Genetic Instability in Werner Syndrome$1,355,674
P01 · FY2007 · CA · contact PI
NEW LAGLIDADG HOMING ENDONUCLEASES FOR GENOME ENGINEERING (Component 2 of 11)$387,200
RL1 · FY2007 · CA · contact PI
Cell Function$260,018
P01 · FY2007 · CA · contact PI
Genetic Instability in Werner Syndrome$1,357,018
P01 · FY2006 · CA · contact PI
Cell Function$166,775
P01 · FY2006 · CA · contact PI
Genetic Instability in Werner Syndrome$1,349,548
P01 · FY2005 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$251,796
R01 · FY2005 · CA
Cell Function$161,917
P01 · FY2005 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$49,207
R01 · FY2005 · CA
Genetic Instability in Werner Syndrome$1,322,838
P01 · FY2004 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$251,796
R01 · FY2004 · CA
Cell Function$157,201
P01 · FY2004 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$49,207
R01 · FY2004 · CA
Administration$48,596
P01 · FY2004 · CA
GENETIC INSTABILITY IN WERNER SYNDROME$1,243,175
P01 · FY2003 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$251,796
R01 · FY2003 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$40,355
R01 · FY2003 · CA
GENETIC INSTABILITY IN WERNER SYNDROME$1,211,685
P01 · FY2002 · CA
GENETIC INSTABILITY IN WERNER CELL LINES$248,412
P01 · FY2002 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$205,200
R01 · FY2002 · CA
GENETIC INSTABILITY IN WERNER SYNDROME$1,175,841
P01 · FY2001 · CA
GENETIC INSTABILITY IN WERNER CELL LINES$248,412
P01 · FY2001 · CA
NOVEL HUMAN GENE SPECIFIC REAGENTS FROM HOMING ENDOS$202,392
R01 · FY2001 · CA
GENETIC INSTABILITY IN WERNER SYNDROME$1,151,074
P01 · FY2000 · CA
OXIDATIVE DNA DAMAGE AND MUTATION IN CELLS$158,867
P01 · FY2000 · AG
GENETIC INSTABILITY IN WERNER CELL LINES$142,296
P01 · FY2000 · CA